Purpose and Summary
H.R. 6160 reauthorizes the Lifespan Respite Care program for five years.
house · Committee report
TO AMEND THE PUBLIC HEALTH SERVICE ACT TO REAUTHORIZE A LIFESPAN RESPITE CARE PROGRAM
2024-05-21
H.R. 6160 reauthorizes the Lifespan Respite Care program for five years.
The program reauthorized under H.R. 6160 is administered by the Administration of Community Living (ACL) at the Department of Health and Human Services (HHS) and supports state respite care systems, which provide respite care for family caregivers of children and adults with disabilities and other chronic conditions.\1\ Respite care provides relief to caregivers, and in doing so, helps to reduce the mental and physical health issues that caregivers might experience. This program was originally authorized through the Lifespan Respite Care Act of 2006 and was last reauthorized through the Lifespan Respite Care Reauthorization Act of 2020.\2\\3\ ACL has awarded competitive grants in thirty-eight states and the District of Columbia since 2009, and these grants have proven to be an effective tool in supporting individuals with chronic conditions and their caregivers.\4\ --------------------------------------------------------------------------- \1\Administration for Community Living, ``Lifespan Respite Care Program'', 2024. https://acl.gov/programs/support-caregivers/lifespan- respite-care-program. \2\Public Law 109-442, Lifespan Respite Care Act of 2006. \3\Public Law 116-324, Lifespan Respite Care Reauthorization Act of 2020. \4\https://acl.gov/programs/support-caregivers/lifespan-respite- care-program. ---------------------------------------------------------------------------
On February 14, 2024, the Subcommittee on Health held a hearing on H.R. 6160. The title of the hearing was ``Legislative Proposals to Support Patients and Caregivers.'' The Subcommittee received testimony from: Andy Shih, PhD, Chief Science Officer, Autism Speaks; Corey Feist, JD, MBA, Co-Founder and CEO, Dr. Lorna Breen Heroes' Foundation; Joanne Pike, DrPH, President and CEO, Alzheimer's Association; Gordon Tomaselli, MD, Former President, American Heart Association; Marilyn and Stanley M. Katz Dean, Emeritus and Professor of Medicine, Albert Einstein College of Medicine; Adjunct Professor of Medicine, Johns Hopkins University School of Medicine; Michelle Whitten, President, CEO, and Co- Founder, Global Down Syndrome Foundation; Randy Strozyk, President, American Ambulance Association; and Christina Annunziata, MD, PhD, Senior Vice President of Extramural Discovery Science, American Cancer Society. On March 12, 2024, the Subcommittee on Health met in open markup session and forwarded H.R. 6160, as amended, to the full Committee by a record vote of 25 yeas and 0 nays. On March 20, 2024, the full Committee on Energy and Commerce met in open markup session and ordered H.R. 6160, as amended, favorably reported to the House by a record vote of 46 yeas and 0 nays.
Clause 3(b) of rule XIII requires the Committee to list the record votes on the motion to report legislation and amendments thereto. The following reflects the record votes taken during the Committee consideration: [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] Oversight Findings and Recommendations Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of rule XIII, the Committee held a hearing and made findings that are reflected in this report. New Budget Authority, Entitlement Authority, and Tax Expenditures Pursuant to clause 3(c)(2) of rule XIII, the Committee finds that H.R. 6160 would result in no new or increased budget authority, entitlement authority, or tax expenditures or revenues.
Pursuant to clause 3(c)(3) of rule XIII, at the time this report was filed, the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974 was not available. Federal Mandates Statement The Committee adopts as its own the estimate of Federal mandates prepared by the Director of the Congressional Budget Office pursuant to section 423 of the Unfunded Mandates Reform Act. Statement of General Performance Goals and Objectives Pursuant to clause 3(c)(4) of rule XIII, the general performance goal or objective of this legislation is to continue existing resources and authorities for the Lifespan Respite Care program to help states support individuals with disabilities and chronic conditions and their caregivers. Duplication of Federal Programs Pursuant to clause 3(c)(5) of rule XIII, no provision of H.R. 6160 is known to be duplicative of another Federal program, including any program that was included in a report to Congress pursuant to section 21 of Public Law 111-139 or the most recent Catalog of Federal Domestic Assistance. Related Committee and Subcommittee Hearings Pursuant to clause 3(c)(6) of rule XIII, the following related hearing was used to develop or consider H.R. 6160: On February 14, 2024, the Subcommittee on Health held a hearing on H.R. 6160. The title of the hearing was ``Legislative Proposals to Support Patients and Caregivers.'' The Subcommittee received testimony from: Andy Shih, PhD, Chief Science Officer, Autism Speaks; Corey Feist, JD, MBA, Co-Founder and CEO, Dr. Lorna Breen Heroes' Foundation; Joanne Pike, DrPH, President and CEO, Alzheimer's Association; Gordon Tomaselli, MD, Former President, American Heart Association; Marilyn and Stanley M. Katz Dean, Emeritus and Professor of Medicine, Albert Einstein College of Medicine; Adjunct Professor of Medicine, Johns Hopkins University School of Medicine; Michelle Whitten, President, CEO, and Co-Founder, Global Down Syndrome Foundation; Randy Strozyk, President, American Ambulance Association; and Christina Annunziata, MD, PhD, Senior Vice President of Extramural Discovery Science, American Cancer Society. Committee Cost Estimate Pursuant to clause 3(d)(1) of rule XIII, the Committee adopts as its own the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974. At the time this report was filed, the estimate was not available. Earmark, Limited Tax Benefits, and Limited Tariff Benefits Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the Committee finds that H.R. 6160 contains no earmarks, limited tax benefits, or limited tariff benefits. Advisory Committee Statement No advisory committees within the meaning of section 5(b) of the Federal Advisory Committee Act were created by this legislation. Applicability to Legislative Branch The Committee finds that the legislation does not relate to the terms and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act. Section-by-Section Analysis of the Legislation Section 1. Reauthorization of lifespan respite care program Section 1 reauthorizes Title XXIX--Lifespan Respite Care of the Public Health Service Act for five fiscal years (fiscal years 2025 through 2029). Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italics, and existing law in which no change is proposed is shown in roman): PUBLIC HEALTH SERVICE ACT * * * * * * * TITLE XXIX--LIFESPAN RESPITE CARE * * * * * * * SEC. 2905. AUTHORIZATION OF APPROPRIATIONS. There are authorized to be appropriated to carry out this title, $10,000,000 for each of [fiscal years 2020 through fiscal year 2024] fiscal years 2025 through 2029. * * * * * * * [all]
Source: https://api.congress.gov/v3/committee-report/118/hrpt/513